Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 19 October 2009, doi:10.1136/bmj.b4291
Cite this as: BMJ 2009;339:b4291
Sophie Cook
1 BMJ
| The first 150 words of the full text of this article appear below. |
The swine flu vaccination programme will begin on Wednesday 21 October, when the first vaccines are distributed to acute trusts for use in "very high risk" patients and healthcare professionals, the chief medical officer Liam Donaldson has announced.
At the Department of Health briefing of 15 October, Professor Donaldson said that he was worried by the fact that the proportion of patients admitted to hospital who are going into intensive care has risen from one in eight to one in five.
He said that the Pandemrix vaccine (GlaxoSmithKline) will reach acute trusts on 21 October and general practices and mental health trusts on 26 October. Celvapan (Baxter) will be distributed from 26 October and will be reserved for patients in priority groups with anaphylactic reactions to egg.
In hospitals, priority will be given to patients at high risk and front line staff. General practices will target pregnant women and people
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses